Jsc Nextgen

This study tests a gene therapy called Neovasculgen in 180 women aged 18-65 with painful bladder syndrome and Hunner's lesions. The goal is to reduce scarring from previous treatments and prevent the bladder from shrinking. Participants receive either the drug or a placebo, and d…

This study tests a new gene therapy called Neovasculgen for women with painful bladder syndrome/interstitial cystitis, a condition causing long-term pelvic pain and frequent urination. The treatment uses a DNA-based medicine to help the bladder heal and prevent shrinkage. The tri…